Tradestie Institutional Equity Comparison Engine

CCCC vs ATYR โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-17 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

ATYR Overall Edge

ATYR Captures Institutional Edge (3โ€“0 Pillars ยท 4โ€“4 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to aTyr Pharma, Inc. Common Stock (ATYR) driven by superior Growth & Margin, Momentum & Technical, Options & Structure. Fundamentally, CCCC trades at N/M Forward P/E with -315.9% operating margin (-24.6% YoY revenue) versus ATYR at N/M Forward P/E and 0.0% operating margin (+0.0% YoY). In options structure, CCCC sits in BREAKDOWN (3rd %ile IV; Dealer Gamma Walls on Pro) against ATYR sits in UNCLASSIFIED (36th %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner Tie
CCCC N/M vs ATYR N/M Fwd P/E
Growth & Margin Winner ATYR
Op Margin -315.9% vs 0.0% ยท YoY -24.6% vs +0.0%
Momentum & Technical Winner ATYR
1Y +1.4% vs +541.4% ยท 52W Pos 23% vs 60%
Options & Structure Winner ATYR
BREAKDOWN (3rd %ile IV) vs UNCLASSIFIED (36th %ile IV)
CCCC NASDAQ
C4 Therapeutics, Inc.
Biological Products, (No Disgnostic Substances)
$2.50
-5.47% 1D
Market Cap $362.4M
1M Return -13.32%
1Y Return +1.42%
Forward P/E N/M
Unified AI Score
47.7 / 100 HOLD
Tech 33.0 Fund 51.0 Flow 64.0 Mom 60.0
ATYR NASDAQ
aTyr Pharma, Inc. Common Stock
Biological Products, (No Disgnostic Substances)
$4.83
-7.82% 1D
Market Cap $15.6M
1M Return +2713.05%
1Y Return +541.43%
Forward P/E N/M
Unified AI Score
34.3 / 100 SELL
Tech 50.0 Fund 36.0 Flow 69.0 Mom 50.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: CCCC +1.42% ATYR +541.43% Spread: +540.01 pp (ATYR Lead)

Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)

Split-Invariant Revenue ($B) & Operating Margin (%)
Period CCCC Revenue ATYR Revenue CCCC Op. Margin ATYR Op. Margin Margin Edge
FY2019 N/A $0M N/A -5445.0% ATYR
FY2020 N/A $10M N/A -152.2% ATYR
FY2021 $50M N/A -179.4% N/A CCCC
FY2022 $30M $10M -416.6% -446.8% CCCC
FY2023 $20M $0M -669.8% -15557.8% CCCC
FY2024 $40M $0M -336.1% -28899.6% CCCC
FY2025 $40M $0M -320.5% -40856.3% CCCC

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: CCCC (4) vs ATYR (4)
Institutional Metric CCCC ATYR Criterion Row Winner
Market Capitalization Scale $362.4M $15.6M Larger Scale CCCC
Trailing P/E Ratio Valuation N/M N/M Lower Multiple Tie
Forward P/E Ratio Valuation N/M N/M Lower Multiple Tie
Revenue Growth (YoY) Growth -24.6% +0.0% Higher Growth ATYR
Operating Margin (TTM) Profitability -315.9% 0.0% Higher Margin ATYR
Net Profit Margin Profitability -282.2% 0.0% Higher Margin ATYR
Return on Equity (ROE) Capital Efficiency -47.6% -93.7% Higher ROE CCCC
52-Week Range Position Momentum 23% ($2โ€“$5) 60% ($0โ€“$8) Stronger Trend ATYR
Beta / 30D Volatility Risk Regime 1.46ฮฒ ยท 68% Vol -9.57ฮฒ ยท 13806% Vol Lower Realized Risk CCCC
Unified Institutional Score Composite Signal 47.7 / 100 (HOLD) 34.3 / 100 (SELL) Higher Composite CCCC

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full CCCC vs ATYR Buy Guide
CCCC BREAKDOWN
118d in phase ยท OBV DISTRIBUTION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 3rd %ile
IV Regime Compressed (<25th %ile)
Live CCCC Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
ATYR UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 36th %ile
IV Regime Balanced (25thโ€“60th %ile)
Live ATYR Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither CCCC nor ATYR registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.